Breaking News, Financial News

Baxter International

Global injectable sales up 14% for the year.

Baxter 3Q10

3Q10 Revenues: $3.2 billion (+3%)

3Q10 Earnings: $595 million (+12%)

YTD Revenues: $9.3 billion (+3%)

YTD Earnings: $1.1 billion (-31%)

Comments: The BioScience unit posted flat sales of $1.4 billion in the quarter, while Medication Delivery sales were up 5% to $1.2 billion. Global injectable sales rose 8% to $469 million in the quarter, and 14% to $1.4 billion for YTD.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters